Registro:

Referencias:

• Guzmán, M.G., Halstead, S.B., Artsob, H., Dengue: A continuing global threat (2010) Nat. Rev. Microbiol, 8 (12), pp. S7-S16. , Suppl
• Bhatt, S., Gething, P.W., Brady, O.J., The global distribution and burden of dengue (2013) Nature, 496 (7446), pp. 504-507
• Halstead, S.B., Dengue (2007) Lancet, 370 (9599), pp. 1644-1652
• Rothman, A.L., Dengue: Defining protective versus pathologic immunity (2004) J. Clin. Invest, 113 (7), pp. 946-951
• Flipse, J., Wilschut, J., Smit, J.M., Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans (2013) Traffic, 14 (1), pp. 25-35
• Yauch, L.E., Shresta, S., Dengue vaccines (2014) Adv. Virus Res, 88, pp. 315-372
• Noble, C.G., Chen, Y.-L., Dong, H., Strategies for development of dengue virus inhibitors (2010) Antiviral Res, 85 (3), pp. 450-462
• Sampath, A., Padmanabhan, R., Molecular targets for flavivirus drug discovery (2009) Antiviral Res, 81 (1), pp. 6-15
• Haggani, A.A., Tilton, J.C., Entry inhibitors and their use in the treatment of HIV-1 infection (2013) Antiviral Res, 98 (2), pp. 158-170
• Spillmann, D., Heparan sulfate: Anchor for viral intruders? (2001) Biochimie, 83 (8), pp. 811-817
• Zhu, W., Li, J., Liang, G., How does cellular heparan sulfate function in viral parhogenicity? (2011) Biomed. Environ. Sci, 24 (1), pp. 81-87
• Chen, Y., Maguire, T., Hileman, R.E., Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate (1997) Nat. Med, 3 (8), pp. 866-871
• Hung, S.L., Lee, P.L., Chen, H.W., Chen, L.K., Kao, C.L., King, C.C., Analysis of the steps involved in dengue virus entry into host cells (1999) Virology, 257 (1), pp. 156-167
• Germi, R., Crance, J.M., Garin, D., Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus (2002) Virology, 292 (1), pp. 162-168
• Martínez-Barragán, J.J., Del Angel, R.M., Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection (2001) J. Virol, 75 (17), pp. 7818-7827
• Hilgard, P., Stockert, R., Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes (2000) Hepatology, 32 (5), pp. 1069-1077
• Dalrymple, N., MacKow, E.R., Productive dengue virus infection of human endothelial cells is directed by heparin sulfate-containing proteoglycan receptors (2011) J. Virol, 85 (18), pp. 9478-9485
• Okamoto, K., Kinoshita, H., Parquet, M.C., Dengue virus strain DEN2 16681 utilizes a specific glycochain of syndecan-2 proteoglycan as a receptor (2012) J. Gen. Virol, 93 (4), pp. 761-770
• Lin, Y.L., Lei, H.Y., Lin, Y.S., Yeh, T.M., Chen, S.H., Liu, H.S., Heparin inhibits dengue-2 virus infection of five human liver cell lines (2002) Antiviral Res, 56 (1), pp. 93-96
• Talarico, L.B., Damonte, E.B., Interference in dengue virus adsorption and uncoating by carrageenans (2007) Virology, 363 (2), pp. 473-485
• Kato, D., Era, S., Watanabe, I., Antiviral activity of chondroitin sulphate e targeting dengue virus envelope protein (2010) Antiviral Res, 88 (2), pp. 236-243
• Vervaeke, P., Alen, M., Noppen, S., Schols, D., Oreste, P., Liekens, S., Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein e domain II (2013) PLoS ONE, 8 (8), p. e74035
• Watterson, D., Kobe, B., Young, P.R., Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding (2012) J. Gen. Virol, 93 (1), pp. 72-82
• Roehrig, J.T., Butrapet, S., Liss, N.M., Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion (2013) Virology, 441 (2), pp. 114-125
• Crill, W.D., Roehrig, J.T., Monoclonal antibodies that bind to domain III of dengue virus e glycoprotein are the most efficient blockers of virus adsorption to Vero cells (2001) J. Virol, 75 (16), pp. 7769-7773
• Ichiyama, K., Gopala Reddy, S.B., Zhang, L.F., Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: A possible candidate for clinical application (2013) PLoS Negl. Trop. Dis, 7 (4), p. e2188
• Marovich, M., Grouard-Vogel, G., Louder, M., Human dendritic cells as targets of human infection (2001) J. Investig. Dermatol. Symp. Proc, 6 (3), pp. 219-224
• Geijtenbeek, T.B., Van Kooyk, Y., Pathogens target DC-SIGN to influence their fate DC-SIGN functions as a pathogen receptor with broad specificity (2003) APMIS, 111 (7-8), pp. 698-714
• Navarro-Sanchez, E., Altmeyer, R., Amara, A., Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses (2003) EMBO Rep, 4 (7), pp. 723-728
• Tassaneetrithep, B., Burgess, T.H., Granelli-Piperno, A., DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells (2003) J. Exp. Med, 197 (7), pp. 823-829
• Lozach, P.-Y., Burleigh, L., Staropoli, I., Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DCSIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals (2005) J. Biol. Chem, 280 (25), pp. 23698-23708
• Pokidysheva, E., Zhang, Y., Battisti, A.J., Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN (2006) Cell, 124 (3), pp. 485-493
• Miller, J.L., Dewet, B.J., Martinez-Pomares, L., The mannose receptor mediates dengue virus infection of macrophages (2008) PLoS Pathog, 4 (2), p. e17
• Chen, Y.C., Wang, S.Y., King, C.C., Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism (1999) J. Virol, 73 (4), pp. 2650-2657
• Reyes-Del Valle, J., Chavez-Salinas, S., Medina, F., Del Angel, R.M., Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells (2005) J. Virol, 79 (8), pp. 4557-4567
• Meertens, L., Carnec, X., Perera Lecoin, M., The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry (2012) Cell Host Microbe, 12 (4), pp. 544-557
• Jindadamrongwech, S., Thepparit, C., Smith, D.R., Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2 (2004) Arch. Virol, 149 (5), pp. 915-927
• Cabrera-Hernández, A., Thepparit, C., Suksanpaisan, L., Smith, D.R., Dengue virus entry into liver (HepG2) cells is independent of hsp90 and hsp70 (2007) J. Med. Virol, 79 (4), pp. 368-392
• Alhoot, M.A., Wang, S.M., Sekaran, S.D., RNA mediated inhibition of dengue virus multiplication and entry in HepG2 cells (2012) PLoS ONE, 7 (3), p. e34060
• Thepparit, C., Smith, D.R., Serotype-specific entry of dengue virus into liver cells: Identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor (2004) J. Virol, 78 (22), pp. 12647-12656
• Tio, P.H., Jong, W.W., Cardosa, M.J., Two dimensional VOPBA reveals laminin receptor (LAMRI) interaction with dengue virus serotypes 1, 2 and 3 (2005) Virol. J., 2, p. 25
• Wei, H.Y., Jiang, L.F., Fang, D.Y., Guo, H.Y., Dengue virus type 2 infects human endothelial cells through binding of the viral envelope glycoprotein to cell surface polypeptides (2003) J. Gen. Virol, 84 (11), pp. 3095-3098
• Yang, J., Zou, L., Hu, Z., Identification and characterization of a 43 kDa actin protein involved in the DENV-2 binding and infection of ECV304 cells (2013) Microbes Infect, 15 (4), pp. 310-318
• Aoki, C., Hidari, K.I., Itonori, S., Identification and characterization of carbohydrate molecules in mammalian cells recognized by dengue virus type 2 (2006) J. Biochem, 139 (3), pp. 607-614
• Wichit, S., Jittmittraphap, A., Hidari, K.I.P.J., Dengue virus type 2 recognizes the carbohydrate moiety of neutral glycosphingolipids in mammalian and mosquito cells (2011) Microbiol. Immunol, 55 (2), pp. 135-140
• Talarico, L.B., Pujol, C.A., Zibetti, R.G., The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell (2005) Antiviral Res, 66 (2-3), pp. 103-110
• Thaisomboonsuk, B.K., Clayson, E.T., Pantuwatana, S., Vaughn, D.W., Endy, T.P., Characterization of dengue-2 virus binding to surfaces of mammalian and insect cells (2005) Am. J. Trop. Med. Hyg, 72 (4), pp. 375-383
• Sinnis, P., Coppi, A., Toida, T., Mosquito heparan sulfate and its potential role in malaria infection and transmission (2007) J. Biol. Chem, 282 (35), pp. 25376-25384
• Talarico, L.B., Noseda, M.D., Ducatti, D.R.B., Duarte, M.E.R., Damonte, E.B., Differential inhibition of dengue virus infection in mammalian and mosquito cells by iotacarrageenan (2011) J. Gen. Virol, 92 (6), pp. 1332-1342
• Hung, J.J., Hsieh, M.T., Young, M.J., Kao, C.L., King, C.C., Chang, W., An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotypespecific binding to mosquito but not mammalian cells (2004) J. Virol, 78 (1), pp. 378-388
• Yazi Mendoza, M., Salas-Benito, J.S., Lanz-Mendoza, H., Hernández-Martínez, S., Del Angel, R.M., A putative receptor for dengue virus in mosquito tissues: Localization of a 45-kDa glycoprotein (2002) Am. J. Trop. Med. Hyg, 67 (1), pp. 76-84
• Mercado-Curiel, R.F., Esquinca-Avilés, H.A., Tovar, R., Díaz-Badillo, A., Camacho-Nuez, M., Muñoz, M.L., The four serotypes of dengue recognize the same putative receptors in Aedes aegypti midgut and Ae. Albopictus cells (2006) BMC Microbiol, 6, p. 85
• Cao-Lorneau, V.M., Dengue viruses binding proteins from Aedes aegypti and Aedes polynesiensis salivary glands (2009) Virol. J., 6, p. 35
• Sakoonwatanyoo, P., Boonsanay, V., Smith, D.R., Growth and production of the dengue virus in C6/36 cells and identification of a laminin-binding protein as a candidate serotype 3 and 4 receptor protein (2006) Intervirology, 49 (3), pp. 161-172
• Salas-Benito, J., Reyes-Del Valle, J., Salas-Benito, M., Ceballos-Olvera, I., Mosso, C., Del Angel, R.M., Evidence that the 45-kD glycoprotein, part of a putative dengue virus receptor complex in the mosquito cell line C6/36, is a heat-shock related protein (2007) Am. J. Trop. Med. Hyg, 77 (2), pp. 283-290
• Chee, H.-Y., Abubakar, S., Identification of a 48 kDa tubulin or tubulin-like C6/36 mosquito cells protein that binds dengue virus 2 using mass spectrometry (2004) Biochem. Biophys. Res. Commun, 320 (1), pp. 11-17
• Kuadkitkan, A., Wikan, N., Fongsaran, C., Smith, D.R., Identification and characterization of prohibitin as a receptor protein mediating DENV-2 entry into insect cells (2010) Virology, 406 (1), pp. 149-161
• Paingankar, M.S., Gokhale, M.D., Deobagkar, D.N., Dengue-2-virus-interacting polypeptides involved in mosquito cell infection (2010) Arch. Virol, 155 (9), pp. 1453-1461
• Hase, T., Summers, P.L., Eckels, K.H., Flavivirus entry into cultured mosquito cells and human peripheral blood monocytes (1989) Arch. Virol, 104 (1-2), pp. 129-143
• Lim, H.Y., Ng, M.L., A different mode of entry by dengue-2 neutralization escape mutant virus (1999) Arch. Virol, 144 (5), pp. 989-995
• Vancini, R., Kramer, L.D., Ribeiro, M., Hernandez, R., Brown, D., Flavivirus infection from mosquitoes in vitro reveals cell entry at the plasma membrane (2013) Virology, 435 (2), pp. 406-414
• Krishnan, M.N., Sukumaran, B., Pal, U., Rab 5 is required for the cellular entry of dengue virus and West Nile viruses (2007) J. Virol, 81 (9), pp. 4881-4885
• Acosta, E.G., Castilla, V., Damonte, E.B., Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin-mediated endocytosis (2008) J. Gen. Virol, 89 (2), pp. 474-484
• Mosso, C., Galván-Mendoza, I.J., Ludert, J.E., Del Angel, R.M., Endocytic pathway followed by dengue virus to infect the mosquito cell line C6/36 H.T (2008) Virology, 378 (1), pp. 193-199
• Acosta, E.G., Castilla, V., Damonte, E.B., Infectious dengue-1 virus entry into mosquito C6/36 cells (2011) Virus Res, 160 (1-2), pp. 163-179
• Hu, H.-P., Hsieh, S.C., King, C.-C., Wang, W.-K., Characterization of retrovirus-based reporter viruses pseudotyped with the precursor membrane and envelope glycoproteins of four serotypes of dengue viruses (2007) Virology, 368 (2), pp. 376-387
• Van Der Schaar, H.M., Rust, M.J., Waarts, B.-L., Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking (2007) J. Virol, 81 (21), pp. 12019-12028
• Kuhn, R.J., Zhang, W., Rossmann, M.G., Structure of dengue virus: Implications for flavivirus organization, maturation and fusion (2002) Cell, 108 (5), pp. 717-725
• Modis, Y., Ogata, S., Clements, D., Harrison, S.C., Structure of the dengue virus envelope protein after membrane fusion (2004) Nature, 427 (6972), pp. 313-319
• Zhang, Y., Zhang, W., Ogata, S., Conformational changes of the flavivirus e glycoprotein (2004) Structure, 12, pp. 1607-1618
• Stiasny, K., Heinz, F.X., Flavivirus membrane fusion (2006) J. Gen. Virol, 87 (10), pp. 2755-2766
• Mercer, J., Schelhaas, M., Helenius, A., Virus entry by endocytosis (2010) Annu. Rev. Biochem, 79, pp. 803-833
• Schelhaas, M., Come in and take your coat off - How host cells provide endocytosis for virus entry (2010) Cell. Microbiol, 12 (10), pp. 1378-1388
• Acosta, E.G., Castilla, V., Damonte, E.B., Alternative infectious entry pathways for dengue virus serotypes into mammalian cells (2009) Cell. Microbiol, 11 (10), pp. 1533-1549
• Peng, T., Wang, J.L., Chen, W., Entry of dengue virus serotype 2 into ECV304 cells depends on clathrin-dependent endocytosis, but not on caveolae-dependent endocytosis (2009) Can. J. Microbiol, 55 (2), pp. 139-145
• Alhoot, M.A., Wang, S.M., Sekaran, S.D., Inhibition of dengue virus entry and multiplication into monocytes using RNA interference (2011) PLoS Negl. Trop. Dis, 5 (11), p. e1410
• Van Der Schaar, H.M., Rust, M.J., Chen, C., Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells (2008) PLoS Pathog, 4 (12), p. e1000244
• Ang, F., Wong, A.P.Y., Ng, M.M.-L., Chu, J.J.H., Small interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virus (2010) Virol. J., 7 (24)
• Mayor, S., Pagano, R.E., Pathways of clathrinindependent endocytosis (2007) Nat. Rev. Mol. Cell Biol, 8 (8), pp. 603-612
• Sanchez, V., Gimenez, S., Tomlinson, B., Innate and adaptive cellular immunity in flavivirus-naive human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3 (2006) Vaccine, 24 (23), pp. 4914-4926
• Lee, H.C., Yen, Y.T., Chen, W.Y., Wu-Hsieh, B.A., Wu, S.C., Dengue type 4 live-attenuated vaccine viruses passaged in Vero cells affect genetic stability and dengue-induced hemorrhaging in mice (2011) PLoS ONE, 6 (10), p. e25800
• Huang, C.Y., Kinney, R.M., Livengood, J.A., Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax) (2013) PLoS Negl. Trop. Dis, 7 (5), p. e2243
• Suksanpaisan, L., Susantad, T., Smith, D.R., Characterization of dengue virus entry into HepG2 cells (2009) J. Biomed. Sci, 16, p. 17
• Zhu, Y.-Z., Xu, Q.-Q., Wu, D.-G., Japanese encephalitis virus enters rat neuroblastoma cells via a pH-dependent, dynamin and caveola-mediated endocytosis pathway (2013) J. Virol, 86 (24), pp. 13407-13422
• Kalia, M., Khasa, R., Sharma, M., Nain, M., Vrati, S., Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism (2013) J. Virol, 87 (1), pp. 148-162
• Carro, A.C., Damonte, E.B., Requirement of cholesterol in the viral envelope for dengue virus infection (2013) Virus Res, 174 (1-2), pp. 78-87
• Lee, C.J., Lin, H.R., Liao, C.L., Lin, Y.L., Cholesterol effectively blocks entry of flavivirus (2008) J. Virol, 82 (13), pp. 6470-6480
• Umashankar, M., Sánchez-San Martín, C., Liao, M., Differential cholesterol binding by class II fusion proteins determines membrane fusion properties (2008) J. Virol, 82 (18), pp. 9245-9253
• Rodman, J.S., Wansinger-Ness, A., Rab GTPases coordinate endocytosis (2000) J. Cell Sci, 113 (2), pp. 183-192
• Stein, M.P., Dong, J., Wandinger-Ness, A., Rab proteins and endocytic trafficking: Potential targets for therapeuticas intervention (2003) Adv. Drug Deliv. Rev, 55 (11), pp. 1421-1437
• Lozach, P.Y., Huotari, J., Helenius, A., Latepenetrating viruses (2011) Curr. Opin. Virol, 1 (1), pp. 35-43
• Zaitseva, E., Yang, S.T., Melikov, K., Pourmal, S., Chernomordik, L.V., Dengue virus ensures its fusion in late endosomes using compartmentspecific lipids (2010) PLoS Pathog, 6 (10), p. e1001131
• Acosta, E.G., Castilla, V., Damonte, E.B., Differential requirements in endocytic trafficking for penetration of dengue virus (2012) PLoS ONE, 7 (9), p. e44835
• Shrivastava, N., Sripada, S., Kaur, J., Shah, P.S., Cecilia, D., Insights into the internalization and retrograde trafficking of dengue virus in BHK-21 cells (2011) PLoS ONE, 6 (10), p. e25229
• Lee, Y.R., Lei, H.Y., Liu, M.T., Autophagic machinery activated by dengue virus enhances virus replication.Virology (2008) Autophagic Machinery Activated by Dengue Virus Enhances Virus Replication.Virology 374(2), 240-248 (2008, 374 (2), pp. 240-248
• Panyasrivanit, M., Khakpoor, A., Wikan, N., Smith, D.R., Co-localization of constituents of the dengue virus translation and replication machinery with amphisomes (2009) J. Gen. Virol, 90, pp. 448-456. , Pt2
• Heaton, N.S., Randall, G., Dengue virusinduced autophagy regulates lipid metabolism (2010) Cell Host Microbe, 8 (5), pp. 422-432
• Khakpoor, A., Panyasrivanit, M., Wikan, N., Smith, D.R., A role for autophagolysosomes in dengue virus 3 production in HepG2 cells (2009) J. Gen. Virol, 90, pp. 1093-1103. , Pt5
• Heaton, N.S., Randall, G., Dengue virus and autophagy (2011) Viruses, 3 (8), pp. 1332-1341
• Lee, Y.R., Hu, H.Y., Kuo, S.H., Dengue virus infection induces autophagy: An in vivo study (2013) J. Biomed. Sci, 20 (65)
• Fang, Y.T., Wan, S.W., Lu, Y.T., Autophagy facilitates antibody-enhanced dengue virus infection in human pre-basophil/mast cells (2014) PLoS ONE, 9 (10), p. e110655
• Ghosh Roy, S., Sadigh, B., Datan, E., Lockshin, R.A., Zakeri, Z., Regulation of cell survival and death during Flavivirus infections (2014) World J. Biol. Chem, 5 (2), pp. 93-105
• De La Guardia, C., Lleonart, R., Progress in the identification of dengue virus entry/fusion inhibitors 2014 (2014) Biomed. Res. Int, , 825039
• Perera, R., Khaliq, M., Kuhn, R.J., Closing the door on flaviviruses: Entry as a target for antiviral drug design (2008) Antiviral Res, 80 (1), pp. 11-22
• Kampmann, T., Yennamalli, R., Campbell, P., In silico screening of small molecule libraries using the dengue virus envelope e protein has identified compounds with antiviral activity against multiple flaviviruses (2009) Antiviral Res, 84 (3), pp. 234-241
• Chin, J.F.L., Chu, J.J.H., Ng, M.L., The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry (2007) Microbes Infect, 9 (1), pp. 1-6
• Alhoot, M.A., Rathinam, A.K., Wang, S.M., Manikam, R., Sekaran, S.D., Inhibition of dengue virus entry into target cells using synthetic antiviral peptides (2013) Int. J. Med. Sci, 10 (6), pp. 719-729
• Lok, S.M., Kostyuchenko, V., Nybakken, G.E., Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins (2008) Nat. Struct. Mol. Biol, 15 (3), pp. 312-317
• Shrestha, B., Brien, J.D., Sukupolvi-Petty, S., The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1 (2010) PLoS Pathog, 6 (4), p. e1000823
• Goncalvez, A.P., Engle, R.E., St Claire, M., Purcell, R.H., Lai, C.J., Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention (2007) Proc. Natl Acad. Sci. USA, 104 (22), pp. 9422-9427
• Alen, M.M., Kaptein, S.J., De Burghgraeve, T., Balzarini, J., Neyts, J., Schols, D., Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection (2009) Virology, 387 (1), pp. 67-75
• Alen, M.M., De Burghgraeve, T., Kaptein, S.J., Balzarini, J., Neyts, J., Schols, D., Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells (2011) PLoS ONE, 6 (6), p. e21658
• Varga, N., Sutkeviciute, I., Ribeiro-Viana, R., A multivalent inhibitor of the DC-SIGN dependent uptake of HIV-1 and dengue virus (2014) Biomaterials, 35 (13), pp. 4175-4184
• Obeid, S., Printsevskaya, S.S., Olsufyeva, E.N., Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics (2011) J. Antimicrob. Chemother, 66 (6), pp. 1287-1294
• De Burghgraeve, T., Kaptein, S.J., Ayala-Nunez, N.V., An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro (2012) PLoS ONE, 7 (5), p. e37244
• Lee, E., Pavy, M., Young, N., Freeman, C., Lobigs, M., Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic Flaviviruses (2006) Antiviral Res, 69 (1), pp. 31-38
• Pujol, C.A., Estévez, J.M., Carlucci, M.J., Ciancia, M., Cerezo, A.S., Damonte, E.B., Novel DL-galactan hybrids from the red seaweed Gymnogongrus torulosus are potent inhibitors of herpes simplex virus and dengue virus (2002) Antivir. Chem. Chemother, 13 (2), pp. 83-89
• Talarico, L.B., Duarte, M.E., Zibetti, R.G., Noseda, M.D., Damonte, E.B., An algal-derived DL-galactan hybrid is an efficient preventing agent for in vitro dengue virus infection (2007) Planta Med, 73 (14), pp. 1464-1468
• Hidari, K.I., Takahashi, N., Arihara, M., Nagaoka, M., Morita, K., Suzuki, T., Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga (2008) Biochem. Biophys. Res. Commun, 376 (1), pp. 91-95
• Pujol, C.A., Ray, S., Ray, B., Damonte, E.B., Antiviral activity against dengue virus of diverse classes of algal sulfated polysaccharides (2012) Int. J. Biol. Macromol, 51 (4), pp. 412-416
• Acosta, E.G., Piccini, L.E., Talarico, L.B., Castilla, V., Damonte, E.B., Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells (2014) Virus Res, 184, pp. 39-43
• Lin, L.T., Chen, T.Y., Lin, S.C., Broadspectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry (2013) BMC Microbiol, 13 (187)
• Costin, J.M., Jenwitheesuk, E., Lok, S.M., Structural optimization and de novo design of dengue virus entry inhibitory peptides (2010) PLoS Negl. Trop. Dis, 4 (6), p. e721
• Kaptein, S.J., De Burghgraeve, T., Froeyen, M., A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro (2010) Antimicrob. Agents Chemother, 54 (12), pp. 5269-5280
• Ayala-Nuñez, N.V., Jarupathirun, P., Kaptein, S.J., Neyts, J., Smit, J.M., Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative (2013) Antiviral Res, 100 (1), pp. 238-245
• Schmidt, A.G., Yang, P.L., Harrison, S.C., Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate (2010) PLoS Pathog, 6 (4), p. e1000851
• Schmidt, A.G., Yang, P.L., Harrison, S.C., Peptide inhibitors of Flavivirus entry derived from the e protein stem (2010) J. Virol, 84 (24), pp. 12549-12554
• Hrobowski, Y.M., Garry, R.F., Michael, S.F., Peptide inhibitors of dengue virus and West Nile virus infectivity (2005) Virol. J., 2, p. 49
• Lok, S.M., Costin, J.M., Hrobowski, Y.M., Release of dengue virus genome induced by a peptide inhibitor (2012) PLoS ONE, 7 (11), p. e50995
• Schmidt, A.G., Lee, K., Yang, P.L., Harrison, S.C., Small-molecule inhibitors of dengue-virus entry (2012) PLoS Pathog, 8 (4), p. e1002627
• Poh, M.K., Yip, A., Zhang, S., A small molecule fusion inhibitor of dengue virus (2009) Antiviral Res, 84 (3), pp. 260-266
• Yang, J.M., Chen, Y.F., Tu, Y.Y., Yen, K.R., Yang, Y.L., Combinatorial computational approaches to identify tetracycline derivatives as Flavivirus inhibitors (2007) PLoS ONE, 2 (5), p. e428
• Rothwell, C., Lebreton, A., Young Ng, C., Cholesterol biosynthesis modulation regulates dengue viral replication (2009) Virology, 389 (1-2), pp. 8-19
• Martínez-Gutierrez, M., Castellanos, J.E., Gallego-Gómez, J.C., Statins reduce dengue virus production via decreased virion assembly (2011) Intervirology, 54 (4), pp. 202-216
• Poh, M.K., Shui, G., Xie, X., Shi, P.Y., Wenk, M.R., Gu, F., U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication (2012) Antiviral Res, 93 (1), pp. 191-198
• Panya, A., Bangphoomi, K., Choowongkomon, K., Yenchitsomanus, P.T., Peptide inhibitors against dengue virus infection (2014) Chem. Biol. Drug des, 84 (2), pp. 148-157
• Zhou, Z., Khaliq, M., Suk, J.E., Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus e protein (2008) ACS Chem. Biol, 3 (12), pp. 765-775
• Wang, Q.Y., Patel, S.J., Vangrevelinghe, E., A small-molecule dengue virus entry inhibitor (2009) Antimicrob. Agents Chemother, 53 (5), pp. 1823-1831
• Rees, C.R., Costin, J.M., Fink, R.C., In vitro inhibition of dengue virus entry by p-sulfoxycinnamic acid and structurally related combinatorial chemistries (2008) Antiviral Res, 80 (2), pp. 135-142
• Tricou, V., Minh, N.N., Van, T.P., A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults (2010) PLoS Negl. Trop. Dis, 4 (8), p. e785
• Borges, M.C., Castro, L.A., Fonseca, B.A., Chloroquine use improves dengue-related symptoms (2013) Mem. Inst. Oswaldo Cruz, 108 (5), pp. 596-599
• Nguyen, N.M., Tran, C.N., Phung, L.K., A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients (2013) J. Infect. Dis, 207 (9), pp. 1442-1450
• Low, J.G., Sung, C., Wijaya, L., Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): A phase 1b, randomised, double-blind, placebo-controlled, proof-ofconcept trial (2014) Lancet Infect. Dis, 14 (8), pp. 706-715
• Whitehorn, J., Van Vinh Chau, N., Truong, N.T., Lovastatin for adult patients with dengue: Protocol for a randomised controlled trial (2012) Trials, 13 (203)
• Krishnan, M.N., Garcia-Blanco, M.A., Targeting host factors to treat West Nile and dengue viral infections (2014) Viruses, 6 (2), pp. 683-708

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------